Last Updated: May 3, 2026

TRIMETH Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Trimeth, and when can generic versions of Trimeth launch?

Trimeth is a drug marketed by Alpharma Us Pharms, Naska, Heritage Pharma Avet, Lupin, Sun Pharm Industries, Am Regent, Bpi Labs, Hospira, Smith And Nephew, Solopak, Watson Labs, Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Teva, Bausch And Lomb, Epic Pharma Llc, Sandoz, and Somerset Theraps Llc. and is included in twenty-six NDAs.

The generic ingredient in TRIMETH is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for TRIMETH?
What are the global sales for TRIMETH?
What is Average Wholesale Price for TRIMETH?

Summary for TRIMETH

US Patents:	0
Applicants:	19
NDAs:	26

US Patents and Regulatory Information for TRIMETH

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	TRIMETH/SULFA	sulfamethoxazole; trimethoprim	SUSPENSION;ORAL	072289-001	May 23, 1988		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Novitium Pharma	TRIMETHOPRIM	trimethoprim	TABLET;ORAL	216393-001	Oct 28, 2022	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Epic Pharma Llc	TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE	polymyxin b sulfate; trimethoprim sulfate	SOLUTION/DROPS;OPHTHALMIC	065006-001	Dec 17, 1998	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Am Regent	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	091330-001	Mar 8, 2011		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Heritage Pharma Avet	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	CAPSULE;ORAL	205950-001	Nov 21, 2023	AB	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Solopak	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	089094-001	Apr 4, 1986		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.